MedPath

NovoMix 30 FlexPen

Brand Name: NovoMix 30 FlexPen

Generic Name: Insulin Aspart

Active
Registration Number

BR-1077

Dosage Form

Suspension for Injection (SC) (Formulation: 30% Soluble Insulin and 70% Protamine Insulin Aspart Crystals)

Issuance Date

March 31, 2025

Expiry Date

April 27, 2031

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 units per mL
Packaging3 mL Pre-filled Pen (Cartridge: Type I Glass) with Red Rubber Plunger, Type I Glass Bead and Cap with Rubber Closure (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Insulins and Analogues
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Insulin AspartActive
Monograph: Insulin aspart

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform